Researchers challenged aspects of the experimental evidence used to link PRKCD inhibition with restored mitophagic flux in a sevoflurane-induced cognitive dysfunction model. The report outlines methodological limitations in how the mitophagy mechanism has been supported and questions the robustness of the interpretive chain. The debate matters for the field’s mechanistic direction: cognitive dysfunction models tied to anesthesia are often used to infer mitochondrial pathways, but confirmation depends on measurement validity and model appropriateness. By focusing on methodological constraints, the authors aim to recalibrate what can be concluded from current preclinical results. For translational programs targeting mitophagy or related mitochondrial quality-control pathways, the critique underscores the need for stronger causal evidence and improved experimental controls before mechanism-based therapies are prioritized.